Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway.
Domenico D'AmicoOlivier BiondiCamille JanuelCynthia BezierDelphine SapalyZoé ClercMirella El KhouryVenkat Krishnan SundaramLéo HoudebineThibaut JosseBruno Della GasperaCécile MartinatCharbel MassaadLaure WeillFrédéric CharbonnierPublished in: Neuropathology and applied neurobiology (2022)
We have identified XBP1s depletion as a contributing factor in SMA pathogenesis, and the modulation of this transcription factor proves to be a plausible therapeutic avenue in the context of pharmacological interventions for patients.